Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?

por de Weerdt, Iris, Kater, Arnon P.
Publicado 2019

Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?

por Haselager, Marco V., Kater, Arnon P., Eldering, Eric
Publicado 2020

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

por Jacobs, Chaja F., Eldering, Eric, Kater, Arnon P.
Publicado 2021

Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk

por van Attekum, Martijn HA, Eldering, Eric, Kater, Arnon P
Publicado 2017

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia

por Hofland, Tom, Eldering, Eric, Kater, Arnon P., Tonino, Sanne H.
Publicado 2019

T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective

por Peters, Fleur S., Strefford, Jonathan C., Eldering, Eric, Kater, Arnon P.
Publicado 2021

Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma

por Thus, Yvonne J., Eldering, Eric, Kater, Arnon P., Spaargaren, Marcel
Publicado 2022

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

por de Weerdt, Iris, Koopmans, Suzanne M., Kater, Arnon P., van Gelder, Michel
Publicado 2017

The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction

por Rolvink, José, Gerards, Anne-Loes E, Kater, Arnon P, Swart, Eleonora L, Becker, Matthijs L
Publicado 2021

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma

por van Bruggen, Jaco A. C., Martens, Anne W. J., Tonino, Sanne H., Kater, Arnon P.
Publicado 2020

Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837

por van Bruggen, Jaco A. C., Martens, Anne W. J., Tonino, Sanne H., Kater, Arnon P.
Publicado 2021

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

por van der Straten, Lina, Hengeveld, Paul J., Kater, Arnon P., Langerak, Anton W., Levin, Mark-David
Publicado 2021

Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature

por Choi, Goda, van den Borne, Maaike P. J., Visser, Caroline E., Kersten, Marie José, Kater, Arnon P.
Publicado 2008

Rare but Serious: Ibrutinib Induced Liver Failure

por Kleijwegt, Fleur S., Roda, Afnan Abdul, Rolvink, José, Kater, Arnon P., Kersten, Marie José, Vos, Josephine M.I.
Publicado 2019

Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia

por Kater, Arnon P., Slinger, Erik, Cretenet, Gaspard, Martens, Anne W., Balasubramanian, Sriram, Leverson, Joel D., Eldering, Eric
Publicado 2021

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia

por Delgado, Raquel, Kielbassa, Karoline, ter Burg, Johanna, Klein, Christian, Trumpfheller, Christine, de Heer, Koen, Kater, Arnon P., Eldering, Eric
Publicado 2021

Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells

por van Bruggen, J. A. C., van der Windt, G. J. W., Hoogendoorn, M., Dubois, J., Kater, Arnon P., Peters, F. S.
Publicado 2022

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/...

por Levin, Mark-David, Kater, Arnon P, Mattsson, Mattias, Kersting, Sabina, Ranti, Juha, Thi Tuyet Tran, Hoa, Nasserinejad, Kazem, Niemann, Carsten Utoft
Publicado 2020

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

por Baliakas, Panagiotis, Espinet, Blanca, Mellink, Clemens, Jarosova, Marie, Athanasiadou, Anastasia, Ghia, Paolo, Kater, Arnon P., Oscier, David, Haferlach, Claudia, Stamatopoulos, Kostas
Publicado 2022

Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands

por van der Straten, Lina, Levin, Mark‐David, Visser, Otto, Posthuma, Eduardus F.M., Doorduijn, Jeanette K., Kater, Arnon P., Dinmohamed, Avinash G.
Publicado 2021